Our findings reveal MALNC as a multi-exonic lncRNA with elevated expression in specific AML subclasses, particularly in APL and non-APL AML with NPM1/IDH2R140co-mutations, which account for 10% and 5% of AML patients, respectively [25, 46]. Here, NPM1 is linked to acute myeloid leukemia.